Astellas Pharma
Stock
Stock
ISIN: JP3942400007
Ticker: 4503
JP3942400007
4503
Price
Price
CHART BY
Historical dividends and forecast
Astellas Pharma has so far distributed $0.244 in 2026. The next dividend will be paid on 01.12.2026
$0.226
CHART BY
Frequently asked questions
What is Astellas Pharma's market capitalization?
The market capitalization of Astellas Pharma is 27.25B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Astellas Pharma's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Astellas Pharma is 11.56. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
Is Astellas Pharma paying dividends?
Yes, Astellas Pharma is paying dividends. The next payment is scheduled for 01.12.2026, with an expected amount of .
What is the free float of Astellas Pharma's shares?
The free float of Astellas Pharma is 1.72B. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- 27.25B
- Free Float
- 1.72B
- P/E ratio (TTM)
- 11.56
Pricing
- 1D span
- $14.96$15.30
- 52W span
- $10.16$16.78
Information
Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products: XTANDI, PADCEV, XOSPATA, VYLOY, VEOZAH, IZERVAY, EVRENZO, BETANIS and PROGRAF. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.
- Industries
- Major Pharmaceuticals
- Sector
- Health Care
Identifier
- ISIN
- JP3942400007
- Primary Ticker
- 4503
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet